Prescription Drug Costs by Condition
Compare prescription drug prices across 41 medical conditions, covering 507 medications and $355.8B in annual Medicare Part D spending.
Top 10 Conditions by Medicare Spending
| # | Condition | Drugs | Medicare Spending |
|---|---|---|---|
| 1 | Cancer | 81 | $92.5B |
| 2 | Diabetes | 41 | $40.0B |
| 3 | Autoimmune Diseases | 23 | $39.7B |
| 4 | Blood Clots | 11 | $24.5B |
| 5 | HIV | 18 | $16.7B |
| 6 | Multiple Sclerosis | 18 | $15.1B |
| 7 | Asthma/COPD | 18 | $14.5B |
| 8 | Mental Health | 20 | $10.6B |
| 9 | Eye Diseases | 17 | $9.4B |
| 10 | High Cholesterol | 19 | $7.5B |
All 41 Conditions by Body System
Cardiovascular (5)
Endocrine & Metabolic (4)
Oncology (1)
Mental Health & Sleep (4)
Neurological (6)
Autoimmune & Rheumatologic (1)
Respiratory & Allergy (1)
Infectious Disease (4)
Kidney & Liver (1)
Digestive (1)
Bone & Joint (2)
Eye & Vision (1)
Rare & Blood Disorders (4)
Transplant & Immunosuppression (1)
Urology & Sexual Health (1)
Dermatology (1)
Women’s Health (1)
Addiction & Dependence (1)
Other Conditions (1)
Frequently Asked Questions
DrugPrice tracks prescription drug costs across 41 medical conditions, from common ones like hypertension and diabetes to specialty categories like rare diseases and oncology.
Cancer leads with $92.5B in annual Medicare Part D spending across 81 medications.
Each drug is mapped to its primary indication based on FDA-approved labeling. Drugs treating multiple conditions (e.g., some diabetes medications also approved for weight loss) may appear under their most common use.
Costs vary with patent status (older conditions have more generics), drug complexity (biologics for autoimmune and cancer cost far more than small-molecule drugs), and market size. Specialty conditions often have fewer but more expensive options.
Related Resources
Conditions are derived from drug-to-indication mapping based on FDA-approved labeling. Multi-indication drugs are assigned to their primary use.